Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Asthma outcomes with benralizumab in...
Conference

Asthma outcomes with benralizumab in biologic-naive and biologic-experienced patients with severe eosinophilic asthma (SEA) in an integrated analysis of the real-world XALOC-1 study

Authors

Nair P; Pelaia G; Emmanuel B; Tran TN; Shih V; Watt M; Kayaniyil S; Boarino S; Nuevo J; Pardal M

Volume

78

Pagination

pp. 252-253

Publisher

WILEY

Publication Date

December 2023

Name of conference

Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)

Conference place

GERMANY, Hamburg

Conference start date

June 9, 2023

Conference end date

June 11, 2023

Conference proceedings

ALLERGY

ISSN

0105-4538

Labels

Fields of Research (FoR)